| Ytd | -50.23% | |
| 1y | -65.69% |
| Open | 0.38 | Prev Close | 0.36 | Low | 0.38 | High | 0.38 | Mkt Cap | 7.67M |
| Vol | 23.72M | Avg Vol | 1.52M | EPS | -0.30 | P/E | -1.19 | Forward P/E | -7.46 |
| Beta | 1.50 | Short Ratio | 0.13 | Inst. Own | 0.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.43 | 200-d Avg | 0.68 | 1yr Est | 9.00 |
LOS ANGELES--(BUSINESS WIRE)---- $KAPA #Bayer--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session
JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7
Kairos Pharma shares surged 22.64% after hours following positive interim safety data from its lead
Toronto, Ontario--(Newsfile Corp. - July 15, 2026) - CEO.CA ("CEO.CA"), the leading investor social